83_FR_10545 83 FR 10498 - National Institute of Mental Health; Notice of Closed Meeting

83 FR 10498 - National Institute of Mental Health; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 47 (March 9, 2018)

Page Range10498-10499
FR Document2018-04805

Federal Register, Volume 83 Issue 47 (Friday, March 9, 2018) 
[Federal Register Volume 83, Number 47 (Friday, March 9, 2018)]
[Notices]
[Pages 10498-10499]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-04805]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel; Career Development and Fellowships in Mental Health 
Services Research.
    Date: March 23, 2018.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Aileen Schulte, Ph.D., Scientific Review 
Officer, Division of Extramural Activities, National Institute of 
Mental Health, NIH Neuroscience Center, 6001 Executive Blvd., Room 
6140, MSC 9608, Bethesda, MD 20892-9608, 301-443-1225, 
[email protected].


[[Page 10499]]


(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental 
Health Research Grants, National Institutes of Health, HHS)

    Dated: March 6, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-04805 Filed 3-8-18; 8:45 am]
BILLING CODE 4140-01-P

10498 Federal Register / Vol. 83, No. 47 / Friday, March 9, 2018 / Notices Dated: March 5, 2018. Place: National Institutes of Health, 6701 Abuse Therapy and Non-Addicting Michelle Trout, Rockledge Drive, Bethesda, MD 20892. Analgesics. Contact Person: Fungai Chanetsa, MPH, Date: April 3, 2018. Program Analyst, Office of Federal Advisory Ph.D., Scientific Review Officer, Center for Time: 1:00 p.m. to 3:30 p.m. Committee Policy. Scientific Review, National Institutes of Agenda: To review and evaluate grant [FR Doc. 2018–04801 Filed 3–8–18; 8:45 am] Health, 6701 Rockledge Drive, Room 3135, applications. BILLING CODE 4140–01–P MSC 7770, Bethesda, MD 20892, 301–408– Place: National Institutes of Health, 6701 9436, fungai.chanetsa@nih.hhs.gov. Rockledge Drive, Bethesda, MD 20892 Name of Committee: Center for Scientific (Telephone Conference Call). DEPARTMENT OF HEALTH AND Review Special Emphasis Panel; RFA: NIH Contact Person: Mary Custer, Ph.D., HUMAN SERVICES Transformative Research Awards (R01) Scientific Review Officer, Center for Review. Scientific Review, National Institutes of National Institutes of Health Date: April 3, 2018. Health, 6701 Rockledge Drive, Room 4148, Time: 8:00 a.m. to 4:30 p.m. MSC 7850, Bethesda, MD 20892, (301) 435– Center for Scientific Review; Notice of Agenda: To review and evaluate grant 1164, custerm@csr.nih.gov. Closed Meetings applications. (Catalogue of Federal Domestic Assistance Place: Washington Marriott Georgetown, Program Nos. 93.306, Comparative Medicine; Pursuant to section 10(d) of the 1221 22nd Street NW, Washington, DC 20037 93.333, Clinical Research, 93.306, 93.333, Federal Advisory Committee Act, as Contact Person: Raymond Jacobson, Ph.D., 93.337, 93.393–93.396, 93.837–93.844, amended, notice is hereby given of the Scientific Review Officer, Center for 93.846–93.878, 93.892, 93.893, National following meetings. Scientific Review, National Institutes of Institutes of Health, HHS) The meetings will be closed to the Health, 6701 Rockledge Drive, Room 5858, Dated: March 5, 2018. MSC 7849, Bethesda, MD 20892, 301–996– public in accordance with the 7702, jacobsonrh@csr.nih.gov. Sylvia L. Neal, provisions set forth in sections Program Analyst, Office of Federal Advisory Name of Committee: Center for Scientific 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Review Special Emphasis Panel; Committee Policy. as amended. The grant applications and Musculoskeletal and Oral Sciences, Imaging, [FR Doc. 2018–04799 Filed 3–8–18; 8:45 am] the discussions could disclose Surgery, and Informatics. BILLING CODE 4140–01–P confidential trade secrets or commercial Date: April 3–4, 2018. property such as patentable material, Time: 8:00 a.m. to 7:00 p.m. and personal information concerning Agenda: To review and evaluate grant DEPARTMENT OF HEALTH AND individuals associated with the grant applications. Place: Embassy Suites at the Chevy Chase HUMAN SERVICES applications, the disclosure of which Pavilion, 4300 Military Road NW, would constitute a clearly unwarranted Washington, DC 20015. National Institutes of Health invasion of personal privacy. Contact Person: Anshumali Chaudhari, Ph.D., Scientific Review Officer, Center for National Institute of Mental Health; Name of Committee: Center for Scientific Notice of Closed Meeting Review Special Emphasis Panel; Member Scientific Review, National Institutes of Conflict: Cardiovascular Sciences. Health, 6701 Rockledge Drive, Room 4124, Pursuant to section 10(d) of the Date: March 29–30, 2018. MSC 7802, Bethesda, MD 20892, (301) 435– 1210, chaudhaa@csr.nih.gov. Federal Advisory Committee Act, as Time: 8:00 a.m. to 5:00 p.m. amended, notice is hereby given of the Agenda: To review and evaluate grant Name of Committee: Center for Scientific applications. Review Special Emphasis Panel; PAR: following meeting. Place: National Institutes of Health, 6701 Adverse Drug Reaction Research. The meeting will be closed to the Rockledge Drive, Bethesda, MD 20892 Date: April 3, 2018. public in accordance with the (Virtual Meeting). Time: 10:00 a.m. to 2:00 p.m. provisions set forth in sections Contact Person: Kimm Hamann, Ph.D., Agenda: To review and evaluate grant 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Scientific Review Officer, Center for applications. as amended. The grant applications and Scientific Review, National Institutes of Place: National Institutes of Health, 6701 the discussions could disclose Health, 6701 Rockledge Drive, Room 4118A, Rockledge Drive, Bethesda, MD 20892 confidential trade secrets or commercial MSC 7814, Bethesda, MD 20892, 301–435– (Virtual Meeting). 5575, hamannkj@csr.nih.gov. Contact Person: Alexander D Politis, Ph.D., property such as patentable material, Scientific Review Officer, Center for and personal information concerning Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA: CA– Scientific Review, National Institutes of individuals associated with the grant 049 Fusion Oncoproteins in Pediatric Cancer. Health, 6701 Rockledge Drive, Room 3210, applications, the disclosure of which Date: April 2–3, 2018. MSC 7808, Bethesda, MD 20892, (301) 435– would constitute a clearly unwarranted Time: 8:00 a.m. to 5:00 p.m. 1150, politisa@csr.nih.gov. invasion of personal privacy. Agenda: To review and evaluate grant Name of Committee: Center for Scientific Name of Committee: National Institute of applications. Review Special Emphasis Panel; Member Mental Health Special Emphasis Panel; Place: Hilton Alexandria Old Town, 1767 Conflict: Neuronal and Glia Function in Career Development and Fellowships in King Street, Alexandria, VA 22314. Neurological Disorders. Mental Health Services Research. Contact Person: Charles Morrow, MD, Date: April 3, 2018. Date: March 23, 2018. Ph.D., Scientific Review Officer, Center for Time: 1:00 p.m. to 4:30 p.m. Time: 11:00 a.m. to 5:00 p.m. Scientific Review, National Institutes of Agenda: To review and evaluate grant Agenda: To review and evaluate grant Health, 6701 Rockledge Drive, Room 6202, applications. applications. MSC 7804, Bethesda, MD 20892, 301–451– Place: National Institutes of Health, 6701 Place: National Institutes of Health, 4467, morrowcs@csr.nih.gov. Rockledge Drive, Bethesda, MD 20892 Neuroscience Center, 6001 Executive Name of Committee: Center for Scientific (Telephone Conference Call). Boulevard, Rockville, MD 20852 (Telephone Contact Person: Carol Hamelink, Ph.D., amozie on DSK30RV082PROD with NOTICES Review Special Emphasis Panel; Global Conference Call). Noncommunicable Diseases and Injury Scientific Review Officer, Center for Contact Person: Aileen Schulte, Ph.D., Across the Lifespan: Exploratory Research Scientific Review, National Institutes of Scientific Review Officer, Division of (R21). Health, 6701 Rockledge Drive, Room 4192, Extramural Activities, National Institute of Date: April 3–4, 2018. MSC 7850, Bethesda, MD 20892, (301) 213– Mental Health, NIH Neuroscience Center, Time: 7:30 a.m. to 5:00 p.m. 9887, hamelinc@csr.nih.gov. 6001 Executive Blvd., Room 6140, MSC 9608, Agenda: To review and evaluate grant Name of Committee: Center for Scientific Bethesda, MD 20892–9608, 301–443–1225, applications. Review Special Emphasis Panel; Opioid aschulte@mail.nih.gov. VerDate Sep<11>2014 16:47 Mar 08, 2018 Jkt 244001 PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 E:\FR\FM\09MRN1.SGM 09MRN1

Federal Register / Vol. 83, No. 47 / Friday, March 9, 2018 / Notices 10499 (Catalogue of Federal Domestic Assistance Name of Committee: National Institute on of Biomedical Imaging and Bioengineering Program No. 93.242, Mental Health Research Drug Abuse Special Emphasis Panel HIV- National Institutes of Health, 6707 Grants, National Institutes of Health, HHS) associated Neuropathic Pain and Opioid Democracy Blvd., Bethesda, MD 20892, (301) Interaction (R01). 451–4794, dennis.hlasta@nih.gov. Dated: March 6, 2018. Date: March 29, 2018. Dated: March 6, 2018. Melanie J. Pantoja, Time: 11:00 a.m. to 3:00 p.m. Program Analyst, Office of Federal Advisory Agenda: To review and evaluate grant David Clary, Committee Policy. applications. Program Analyst, Office of Federal Advisory [FR Doc. 2018–04805 Filed 3–8–18; 8:45 am] Place: National Institutes of Health, Committee Policy. BILLING CODE 4140–01–P Neuroscience Center, 6001 Executive [FR Doc. 2018–04803 Filed 3–8–18; 8:45 am] Boulevard, Rockville, MD 20852 (Telephone BILLING CODE 4140–01–P Conference Call). DEPARTMENT OF HEALTH AND Contact Person: Julia Berzhanskaya, Ph.D., Scientific Review Officer, Office of DEPARTMENT OF HEALTH AND HUMAN SERVICES Extramural Policy and Review, Division of HUMAN SERVICES Extramural Research, National Institute on National Institutes of Health Drug Abuse, NIH, DHHS, 6001 Executive National Institutes of Health Boulevard, Room 4234, MSC 9550, Bethesda, National Institute on Drug Abuse; MD 20892, 301–827–5840, Government-Owned Inventions; Notice of Closed Meetings julia.berzhanskaya@nih.gov. Availability for Licensing Pursuant to section 10(d) of the (Catalogue of Federal Domestic Assistance Federal Advisory Committee Act, as Program Nos.: 93.279, Drug Abuse and AGENCY: National Institutes of Health, amended, notice is hereby given of the Addiction Research Programs, National HHS. following meetings. Institutes of Health, HHS) ACTION: Notice. The meetings will be closed to the Dated: March 6, 2018. public in accordance with the Natasha M. Copeland, SUMMARY: The invention listed below is provisions set forth in sections owned by an agency of the U.S. Program Analyst, Office of Federal Advisory 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Committee Policy. Government and is available for as amended. The grant applications and licensing to achieve expeditious [FR Doc. 2018–04804 Filed 3–8–18; 8:45 am] the discussions could disclose commercialization of results of BILLING CODE 4140–01–P confidential trade secrets or commercial federally-funded research and property such as patentable material, development. Foreign patent and personal information concerning applications are filed on selected DEPARTMENT OF HEALTH AND individuals associated with the grant inventions to extend market coverage HUMAN SERVICES applications, the disclosure of which for companies and may also be available would constitute a clearly unwarranted National Institutes of Health for licensing. invasion of personal privacy. FOR FURTHER INFORMATION CONTACT: National Institute of Biomedical Jenish Patel, Ph.D., 240–669–2894; Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Cutting- Imaging and Bioengineering; Notice of jenish.patel@nih.gov. Licensing Edge Basic Research Awards (CEBRA) (R21). Closed Meeting information and copies of the U.S. Date: March 20, 2018. patent application listed below may be Pursuant to section 10(d) of the Time: 12:00 p.m. to 8:00 p.m. obtained by communicating with the Agenda: To review and evaluate grant Federal Advisory Committee Act, as indicated licensing contact at the applications. amended, notice is hereby given of the Technology Transfer and Intellectual Place: National Institutes of Health, following meeting. The meeting will be closed to the Property Office, National Institute of Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Virtual public in accordance with the Allergy and Infectious Diseases, 5601 Meeting). provisions set forth in sections Fishers Lane, Rockville, MD 20852; tel. Contact Person: Susan O. McGuire, Ph.D., 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 301–496–2644. A signed Confidential Scientific Review Officer, Office of as amended. The grant applications and Disclosure Agreement will be required Extramural Policy and Review, National to receive copies of unpublished patent Institute on Drug Abuse, National Institutes the discussions could disclose confidential trade secrets or commercial applications. of Health, DHHS, 6001 Executive Blvd., property such as patentable material, SUPPLEMENTARY INFORMATION: Room 4245, Rockville, MD 20852, (301) 827– 5817, mcguireso@mail.nih.gov. and personal information concerning Technology description follows. Name of Committee: National Institute on individuals associated with the grant Protein Nanoparticles for Antigen Drug Abuse Special Emphasis Panel applications, the disclosure of which Display in Vaccines Development of a Device to Objectively would constitute a clearly unwarranted Measure Pain (R41/R42/R43/R44). invasion of personal privacy. Description of Technology Date: March 29, 2018. The technology relates to a protein- Time: 9:00 a.m. to 3:00 p.m. Name of Committee: National Institute of Agenda: To review and evaluate grant Biomedical Imaging and Bioengineering based nanoparticle platform that allows applications. Special Emphasis Panel; BRAIN Initiative: presentation of immunogenic molecules Place: National Institutes of Health, Theories, Models and Methods for Analysis such as influenza virus antigens. This Neuroscience Center, 6001 Executive of Complex Data for the Brain, (2018/08). protein platform is made up of hepatitis Boulevard, Rockville, MD 20852. Date: April 12, 2018. B capsid/core proteins. The core Time: 8:00 a.m. to 7:00 p.m. amozie on DSK30RV082PROD with NOTICES Contact Person: Julia Berzhanskaya, Ph.D., proteins contain immunogenic loop c/ Scientific Review Officer, Office of Agenda: To review and evaluate grant e1, where other antigens can be inserted Extramural Policy and Review, Division of applications. Extramural Research, National Institute on Place: Residence Inn Arlington Capital and the chimeric protein retains the Drug Abuse, NIH, DHHS, 6001 Executive View, 2850 South Potomac Avenue, ability to form capsid-like particles. The Boulevard, Room 4234, MSC 9550, Bethesda, Arlington, VA 22202. technology describes the insertion of MD 20892, 301–827–5840, Contact Person: Dennis Hlasta, Ph.D., one or more copies of influenza epitopes julia.berzhanskaya@nih.gov. Scientific Review Officer, National Institute derived from the globular head or the VerDate Sep<11>2014 16:47 Mar 08, 2018 Jkt 244001 PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 E:\FR\FM\09MRN1.SGM 09MRN1


Document Created: 2018-03-09 03:48:52
Document Modified: 2018-03-09 03:48:52
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMarch 23, 2018.
FR Citation83 FR 10498 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR